Detection of MicroRNA-155 based on lambda exonuclease selective digestion and CRISPR/cas12a-assisted amplification

Haotian Zhang1, Jun Xu1, Shiwen Liu2

  • 1Key Lab of Fluorine and Silicon for Energy Materials and Chemistry of Ministry of Education, College of Chemistry and Chemical Engineering, Jiangxi Normal University, Nanchang, 330022, PR China.

PubMed

Insights

A novel biosensor effectively detects the miRNA-155 gene, crucial in many cancers. This highly sensitive and specific tool shows promise for early cancer screening using fluorescence detection.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Cancer Research

Background:

  • MicroRNA-155 (miRNA-155) is overexpressed in many cancers, promoting oncogenesis by inhibiting apoptosis.
  • Sensitive detection of miRNA-155 is vital for early cancer screening and diagnosis.

Purpose of the Study:

  • To develop a highly sensitive and specific biosensor for detecting the miRNA-155 gene.
  • To establish a fluorescence-based detection method for miRNA-155.

Main Methods:

  • A hairpin probe was designed to bind the miRNA-155 gene.
  • Lambda nucleic acid exonuclease was used to cleave the 5' phosphorylated double strand.
  • Cas12a enzyme was activated by a DNA probe to catalyze trans-cutting, generating fluorescence.

Main Results:

  • A strong linear correlation was observed between the logarithm of target concentration and fluorescence intensity.
  • The limit of detection (LOD) for the miRNA-155 gene was determined to be 8.3 pM.
  • The biosensor demonstrated high specificity, low false-positive rates, and excellent sensitivity in serum samples.

Conclusions:

  • The developed biosensor offers a sensitive, selective, and user-friendly method for miRNA-155 detection.
  • This biosensor holds significant potential for advancing early cancer detection strategies.

Related Concept Videos